CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

CUHK Joint Research Sets a New Global Direction for Lung Cancer Treatment Molecular Targeted Therapy Proved more Effective in Treating Patients with ALK-Positive Lung Cancer

CU Medicine and CTTQ sign a Cooperation Framework Agreement Leverage the strengths of mainland China and Hong Kong in pharmaceutical innovations, talent development & commercialisation of medical products

CU Medicine receives the Li Ka Shing Foundation’s donation of Asia’s first Histotripsy 2.0 system 30 patients sponsored to receive novel treatment for liver tumours

CUHK Professor Dennis Lo receives the inaugural Tengchong Science Prize

CUHK Professor Dennis Lo elected as member of the Chinese Academy of Sciences

International lung cancer study involving CU Medicine shows that a targeted therapy doubles the progression-free survival of advanced cancer patients, compared to standard treatment

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK Professor Dennis Lo Receives the Lasker Award, America’s Top Biomedical Science Prize

CUHK’s HK-HOPE develops an integrated drug and genomic test to tailor precision personalised medicine and deliver “hope” to children with difficult-to-treat leukaemia

Three CU Medicine scholars named in world’s “Top 20 Translational Researchers” Professor Dennis LO receives the honour for the fifth consecutive year

CUHK Professor Dennis LO Becomes the First Chinese Scientist to Receive the Royal Medal for Outstanding Achievements in Biological Sciences

CUHK Receives HK$30 million Donation from Li Ka Shing Foundation to Enhance Research Space and Facilities at CU Medicine

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis LO Receives the Honour for the Fourth Consecutive Year

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

CUHK Research Receives Recognitions by Top Medical Journals

Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

CUHK Professor Dennis Lo Awarded King Faisal International Prize for Medicine

CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

CUHK Research Pioneer in Non-invasive Prenatal Diagnosis Elected to US National Academy of Sciences

CUHK Launches Non-invasive Prenatal Test for Down Syndrome 15 Years of Research Comes to Fruition